SymbolRZLT
NameREZOLUTE, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address201 REDWOOD SHORES PARKWAY,SUITE 315, REDWOOD CITY, California, 94065, United States
Telephone+1 650 206-4507
Fax
Email
Websitehttps://www.rezolutebio.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001509261
Description

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Additional info from NASDAQ:
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

2026-08-14 07:09

New Form SCHEDULE 13G/A - Rezolute, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003436 <b>Size:</b> 15 KB

Read more
2026-08-12 13:27

New Form SCHEDULE 13G/A - Rezolute, Inc. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0000070858-26-000432 <b>Size:</b> 171 KB

Read more
2026-08-12 12:06

New Form SCHEDULE 13G - Rezolute, Inc. <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001943462-26-000006 <b>Size:</b> 76 KB

Read more
2026-07-21 11:30

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Read more
2026-07-21 11:30

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Read more
2026-07-07 22:36

ROBERTS BRIAN KENNETH 🔴 sold 3.1K shares of Rezolute, Inc. (RZLT) at $4.99 Transaction Date: Jul 02, 2026 | Filing ID: 000936

Read more
2026-07-07 21:27

Elam Nevan C 🔴 sold 8.0K shares of Rezolute, Inc. (RZLT) at $4.99 Transaction Date: Jul 02, 2026 | Filing ID: 000930

Read more
2026-07-07 21:26

Evans Daron 🔴 sold 3.1K shares of Rezolute, Inc. (RZLT) at $4.99 Transaction Date: Jul 02, 2026 | Filing ID: 000929

Read more
2026-06-17 11:00

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society

Read more
2026-06-04 11:30

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Read more